These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New 5-(nitroheteroaryl)-1,3,4-thiadiazols containing acyclic amines at C-2: synthesis and SAR study for their antileishmanial activity. Tahghighi A, Emami S, Razmi S, Rezazade Marznaki F, Kabudanian Ardestani S, Dastmalchi S, Kobarfard F, Shafiee A, Foroumadi A. J Enzyme Inhib Med Chem; 2013 Aug; 28(4):843-52. PubMed ID: 22651800 [Abstract] [Full Text] [Related]
3. Synthesis and in vitro leishmanicidal activity of 2-(5-nitro-2-furyl) and 2-(5-nitro-2-thienyl)-5-substituted-1,3,4-thiadiazoles. Foroumadi A, Pournourmohammadi S, Soltani F, Asgharian-Rezaee M, Dabiri S, Kharazmi A, Shafiee A. Bioorg Med Chem Lett; 2005 Apr 15; 15(8):1983-5. PubMed ID: 15808452 [Abstract] [Full Text] [Related]
4. Synthesis and anti-leishmanial activity of 5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-amines containing N-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl] moieties. Tahghighi A, Razmi S, Mahdavi M, Foroumadi P, Ardestani SK, Emami S, Kobarfard F, Dastmalchi S, Shafiee A, Foroumadi A. Eur J Med Chem; 2012 Apr 15; 50():124-8. PubMed ID: 22336386 [Abstract] [Full Text] [Related]
7. Synthesis and antileishmanial activity of novel 5-(5-nitrofuran-2-y1)-1,3,4-thiadiazoles with piperazinyl-linked benzamidine substituents. Tahghighi A, Marznaki FR, Kobarfard F, Dastmalchi S, Mojarrad JS, Razmi S, Ardestani SK, Emami S, Shafiee A, Foroumadi A. Eur J Med Chem; 2011 Jun 15; 46(6):2602-8. PubMed ID: 21501907 [Abstract] [Full Text] [Related]
8. Selective leishmanicidal effect of 1,3,4-thiadiazole derivatives and possible mechanism of action against Leishmania species. Poorrajab F, Ardestani SK, Foroumadi A, Emami S, Kariminia A, Behrouzi-Fardmoghadam M, Shafiee A. Exp Parasitol; 2009 Apr 15; 121(4):323-30. PubMed ID: 19124020 [Abstract] [Full Text] [Related]
9. Nitroimidazolyl-1,3,4-thiadiazole-based anti-leishmanial agents: synthesis and in vitro biological evaluation. Poorrajab F, Ardestani SK, Emami S, Behrouzi-Fardmoghadam M, Shafiee A, Foroumadi A. Eur J Med Chem; 2009 Apr 15; 44(4):1758-62. PubMed ID: 18485538 [Abstract] [Full Text] [Related]
10. 4-Arylamino-6-nitroquinazolines: Synthesis and their activities against neglected disease leishmaniasis. Saad SM, Ghouri N, Perveen S, Khan KM, Choudhary MI. Eur J Med Chem; 2016 Jan 27; 108():13-20. PubMed ID: 26619389 [Abstract] [Full Text] [Related]
11. Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazines. Behrouzi-Fardmoghadam M, Poorrajab F, Ardestani SK, Emami S, Shafiee A, Foroumadi A. Bioorg Med Chem; 2008 Apr 15; 16(8):4509-15. PubMed ID: 18321711 [Abstract] [Full Text] [Related]
13. Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines. Khan I, Zaib S, Ibrar A, Rama NH, Simpson J, Iqbal J. Eur J Med Chem; 2014 May 06; 78():167-77. PubMed ID: 24681981 [Abstract] [Full Text] [Related]
14. Synthesis, antileishmanial activity and cytotoxicity of 2,3-diaryl- and 2,3,8-trisubstituted imidazo[1,2-a]pyrazines. Marchand P, Bazin MA, Pagniez F, Rivière G, Bodero L, Marhadour S, Nourrisson MR, Picot C, Ruchaud S, Bach S, Baratte B, Sauvain M, Pareja DC, Vaisberg AJ, Le Pape P. Eur J Med Chem; 2015 Oct 20; 103():381-95. PubMed ID: 26383125 [Abstract] [Full Text] [Related]
15. Synthesis of Novel Quaternary Ammonium Salts and Their in Vitro Antileishmanial Activity and U-937 Cell Cytotoxicity. Duque-Benítez SM, Ríos-Vásquez LA, Ocampo-Cardona R, Cedeño DL, Jones MA, Vélez ID, Robledo SM. Molecules; 2016 Mar 29; 21(4):381. PubMed ID: 27043509 [Abstract] [Full Text] [Related]
16. Synthesis and antibacterial activity of nitroaryl thiadiazole-gatifloxacin hybrids. Jazayeri S, Moshafi MH, Firoozpour L, Emami S, Rajabalian S, Haddad M, Pahlavanzadeh F, Esnaashari M, Shafiee A, Foroumadi A. Eur J Med Chem; 2009 Mar 29; 44(3):1205-9. PubMed ID: 18950903 [Abstract] [Full Text] [Related]
17. Novel antileishmanial chalconoids: synthesis and biological activity of 1- or 3-(6-chloro-2H-chromen-3-yl)propen-1-ones. Nazarian Z, Emami S, Heydari S, Ardestani SK, Nakhjiri M, Poorrajab F, Shafiee A, Foroumadi A. Eur J Med Chem; 2010 Apr 29; 45(4):1424-9. PubMed ID: 20074836 [Abstract] [Full Text] [Related]
18. Novel 5-(nitrothiophene-2-yl)-1,3,4-Thiadiazole Derivatives: Synthesis and Antileishmanial Activity against promastigote stage of Leishmania major. Sadat-Ebrahimi SE, Mirmohammadi M, Mojallal Tabatabaei Z, Azimzadeh Arani M, Jafari-Ashtiani S, Hashemian M, Foroumadi P, Yahya-Meymandi A, Moghimi S, Moshafi MH, Norouzi P, Kabudanian Ardestani S, Foroumadi A. Iran J Pharm Res; 2019 Apr 29; 18(4):1816-1822. PubMed ID: 32184848 [Abstract] [Full Text] [Related]
19. Ultrastructural Investigation of Leishmania major Promastigotes Treated with A New Potent Antileishmanial Azole Using Scanning Electron and Atomic Force Microscopes. Shokri A, Fakhar M, Emami S, Gill P, Akhtari J. Recent Pat Antiinfect Drug Discov; 2018 Apr 29; 13(3):246-255. PubMed ID: 30227826 [Abstract] [Full Text] [Related]